FRONTEO and Otsuka Pharmaceutical have launched a co-creation project to jointly identify drug discovery targets in the renal field. The announcement was made on 27 October 2026 and published as a timely disclosure.
FRONTEO and Otsuka Pharmaceutical announced that they had launched a co-creation project to identify drug discovery targets in the renal field. The main news is the launch of this joint project.
The announcement was made at 16:00 on 27 October 2026 and is said to have been published as a timely disclosure bulletin. The article does not provide details such as specific contract terms, the funding scale or the project period.
The article reports that the two companies will jointly identify targets for drug discovery in the renal field, and provides no other supplementary information at this time.